Temasek Holdings has reduced its stake in Amyris Biotechnologies by 1.12%. Currently Temasek now owns 36.12% of the industrial bioscience materials company.
Amyris is an integrated renewable products company providing sustainable alternatives to a broad range of petroleum-sourced products. Amyris uses its industrial synthetic biology platform to convert plant sugars into a variety of hydrocarbon molecules, flexible building blocks which can be used in a wide range of products.
First Republic Investment Management is the most positive institutional investor on Amyris, with it being at less than 0.01% of its stock portfolio. Temasek Holdings Private Ltd is another positive institutional investor, with Amyris composing 0.19% of its stocks portfolio.